MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

Black Diamond Therapeutics, Inc. (BDTX)

Black Diamond Therapeutics, Inc. (BDTX)

|||

Balance Sheets Overview

Current Ratio
728.36%
Quick Ratio
728.36%
Cash Ratio
121.15%
Debt to Asset Ratio
23.15%
Unit: Thousand (K) dollars
Assets Breakdown
    • Cash and cash equivalents
    • Right-of-use assets
    • Prepaid expenses and other curre...
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Non-current operating lease liab...
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
19,194
30,071
20,990
30,864
Investments
91,312
88,187
107,662
104,639
Prepaid expenses and other current assets
4,888
4,709
3,788
3,489
Total current assets
115,394
122,967
132,440
138,992
Property and equipment, net
310
338
365
1,128
Restricted cash
833
831
829
827
Right-of-use assets
8,207
8,757
9,303
16,669
Other non-current assets
285
29
73
117
Total assets
125,029
132,922
143,010
157,733
Accounts payable
1,404
2,969
579
975
Accrued expenses and other current liabilities
14,439
11,565
15,152
14,570
Total current liabilities
15,843
14,534
15,731
15,545
Non-current operating lease liabilities
13,095
14,088
15,068
16,036
Total liabilities
28,938
28,622
30,799
31,581
Common stock 0.0001 par value 500,000,000 shares authorized at june30, 2026 and december31, 2025 57,446,349 shares issued and outstanding at june30, 2026 and 57,138,057 shares issued and outstanding at december31, 2025
8
8
8
8
Additional paid-in capital
579,832
578,104
576,842
575,626
Accumulated other comprehensive (loss) income
-68
-36
101
142
Accumulated deficit
-483,681
-473,776
-464,740
-449,624
Total stockholders' equity
96,091
104,300
112,211
126,152
Total liabilities and stockholders' equity
125,029
132,922
143,010
157,733
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Investments$91,312K (-19.08%↓ Y/Y)Cash and cashequivalents$19,194K (-36.01%↓ Y/Y)Prepaid expenses andother current assets$4,888K (25.43%↑ Y/Y)Total current assets$115,394K (-21.35%↓ Y/Y)Right-of-use assets$8,207K (-53.00%↓ Y/Y)Restricted cash$833K (1.09%↑ Y/Y)Property and equipment,net$310K (-74.46%↓ Y/Y)Other non-currentassets$285K (77.02%↑ Y/Y)Total assets$125,029K (-24.86%↓ Y/Y)Total liabilities andstockholders' equity$125,029K (-24.86%↓ Y/Y)Total stockholders'equity$96,091K (-27.54%↓ Y/Y)Total liabilities$28,938K (-14.32%↓ Y/Y)Accumulated deficit-$483,681K (-9.65%↓ Y/Y)Accumulated othercomprehensive (loss) income-$68K (-172.00%↓ Y/Y)Additional paid-in capital$579,832K (1.06%↑ Y/Y)Total currentliabilities$15,843K (-5.72%↓ Y/Y)Non-current operating leaseliabilities$13,095K (-22.83%↓ Y/Y)Common stock 0.0001 parvalue 500,000,000...$8K (14.29%↑ Y/Y)Accrued expenses andother current...$14,439K (-9.95%↓ Y/Y)Accounts payable$1,404K (82.10%↑ Y/Y)